Conto economico
CAPRICOR THERAPEUTICS, INC.
CAPR
Riepilogo performance
Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ricavi
|
0.00 | 22.27 | 25.18 | 2.55 | 0.24 | 0.31 | 1.01 | 1.67 | 2.67 | 4.00 | 5.52 | 4.79 | - | 0.20 | 1.35 |
|
Costo del venduto
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Utile lordo
|
- | 22.27 | 25.18 | 2.55 | 0.24 | 0.31 | 1.01 | 1.67 | 2.67 | 4.00 | 5.52 | 4.79 | - | 0.20 | 1.35 |
|
Spese operative
|
108.14 | 64.84 | 49.26 | 32.25 | 21.18 | 14.00 | 8.74 | 17.00 | 15.53 | 20.98 | 18.13 | 10.80 | 7.41 | 2.64 | 6.25 |
|
Ricerca e sviluppo
|
84.45 | 50.00 | 36.45 | 21.82 | 13.60 | 8.46 | 5.14 | 12.07 | 10.77 | 16.04 | 13.76 | 7.79 | 5.20 | 1.02 | 4.14 |
|
Spese commerciali, generali e amministrative
|
23.69 | 14.87 | 12.81 | 10.43 | 7.61 | 5.54 | 3.60 | 4.93 | 4.76 | 4.93 | 4.37 | 3.02 | 2.21 | 1.61 | 2.12 |
|
Altre spese operative
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Reddito operativo
|
-108.14 | -42.56 | -24.08 | -29.70 | -20.94 | -13.69 | -7.73 | -15.33 | -12.86 | -16.98 | -12.61 | -6.02 | -7.41 | -2.44 | -4.90 |
|
Proventi/oneri non operativi
|
3.10 | 2.10 | 1.79 | 0.68 | 0.92 | 0.03 | 0.09 | 0.14 | 15.29 | -1.83 | -0.25 | -0.20 | -1.99 | 0.55 | 0.01 |
|
Proventi da interessi
|
6.26 | 2.20 | 1.73 | 0.52 | 0.06 | 0.03 | 0.09 | 0.14 | 0.04 | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 |
|
Oneri finanziari
|
- | - | - | - | - | - | - | 0.00 | 0.40 | 0.34 | 0.25 | 0.20 | 0.06 | 0.00 | - |
|
Altri proventi/oneri non operativi
|
-0.11 | - | - | - | - | - | - | - | - | - | - | - | - | 0.55 | 0.01 |
|
Risultato prima delle imposte
|
-105.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Imposte sul reddito
|
0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Utile di pertinenza di terzi
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Utile netto
|
-105.04 | -40.47 | -22.29 | -29.02 | -20.02 | -13.66 | -7.64 | -15.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.89 | -4.88 |
Informazioni supplementari
Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ammortamenti e svalutazioni
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-106.25 | -41.14 | -23.01 | -29.16 | -20.69 | -13.55 | -7.56 | -15.17 | -12.72 | -16.85 | -12.50 | -5.98 | -7.38 | -2.43 | -4.89 |
|
Utile per azione (base)
|
-2.26 | -1.15 | -0.83 | -1.18 | -0.87 | - | - | - | 0.10 | - | - | - | - | - | - |
|
Utile per azione diluito
|
-2.26 | -1.15 | -0.83 | -1.18 | -0.87 | - | - | -0.52 | 0.09 | - | - | - | - | - | - |
|
Media ponderata azioni
|
46.48 | 35.22 | 26.78 | 24.55 | 23.09 | 15.57 | 3.71 | 29.41 | 23.19 | - | - | - | - | - | - |
|
Media ponderata diluita azioni
|
46.48 | 35.22 | 26.78 | 24.55 | 23.09 | 15.57 | 3.71 | 29.41 | 26.79 | - | - | - | - | - | - |
|
Conto economico complessivo
|
-105.79 | -39.68 | -22.16 | -28.90 | -20.00 | -13.66 | -7.65 | -15.19 | 2.44 | -18.81 | -12.85 | -6.22 | 0.00 | - | - |